Trial Profile
Effect of LY2216684 on the Pharmacokinetics of Digoxin in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Edivoxetine (Primary) ; Digoxin
- Indications Atrial fibrillation; Atrial flutter; Attention-deficit hyperactivity disorder; Major depressive disorder
- Focus Pharmacokinetics
- 11 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2011 Planned End Date changed from 1 Jun 2011 to 1 Feb 2011 as reported by ClinicalTrials.gov.
- 27 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.